Testing effectiveness (Phase 2)Ended earlyNCT03336242
What this trial is testing
Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures
Who this might be right for
Childhood Absence Epilepsy
Radius Pharmaceuticals, Inc. 20